Artificial and Human Intelligence: Partners in Bionic Healthcare Innovation

Bionics, robotics and artificial intelligence (AI) are already powerful partners – this is a three-way marriage that has the potential to shift our human life span, health, cognition and capabilities.

Timely and cost-efficient access to scalable, massively-parallel computing platforms was vitally important to Dr Nigel Greenwood’s Diabetes Neuromathix team to run AI algorithms associated with their Australian-developed artificial pancreas software. Other bionics researchers around the world face similar challenges.

With the Asia Pacific medtech market now home to 60 percent of the world’s population, a quarter of whom will be over the age of 50 by 2025, the value to be delivered by AI-enabled bionic devices and organ software is very evident.

Read the full G7 Global Briefing Report from Bionics Gamechangers CEO, Dr Robyn Stokes.